6-K ·Filed Jun 18, 2026

GRFS

Grifols SA
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SEC0001104659-26-075705
Notable filing: 6-K
Actionable Insight • Neutral

The filing is routine and unlikely to move the stock. Traders should monitor for actual execution of the share buyback or capital reduction, which could provide modest EPS accretion. The renewed NASDAQ listing delegation keeps the potential for a U.S. listing alive but remains optional. The dividend payment on July 2 is a minor cash event.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GRFS ▲ +1.10% at T+60d
NEUTRAL call ✓ call won +1.10% · α vs SPY -0.65% · entry $7.28 → $7.36
Entry anchored
Jun 18, 03:59 PM ET
via exchange tick
T+1d
-1.37%
call -1.37% · α +0.08%
$7.18
settled 3mo ago
T+5d
+1.51%
call +1.51% · α +3.58%
$7.39
settled 3mo ago
T+20d
-0.14%
call -0.14% · α +0.01%
$7.27
settled 2mo ago
T+60d
+1.10%
call +1.10% · α -0.65%
$7.36
settled 17d ago

Price Chart

Loading chart...

Executive Summary

Grifols SA reported the results of its Ordinary General Shareholders' Meeting held on June 18, 2026. Shareholders approved the FY2025 annual accounts (profit of EUR 192,054 thousand), the distribution of an ordinary dividend of EUR 56,065,663 and a preferred dividend of EUR 2,614,251 for Class B shares, both payable July 2, 2026. The meeting also authorized a share capital reduction of up to 10% via treasury share redemption, renewed the delegation to list Class A shares on NASDAQ, and approved director re-elections and remuneration policy amendments. Item 11 (calling extraordinary meetings with 15 days' notice) failed to pass. This is a routine governance filing with no material new financial disclosures.

Key Facts

  • FY2025 individual profit of EUR 192,054 thousand approved
  • Ordinary dividend of EUR 56,065,663 and preferred dividend of EUR 2,614,251 declared, payable July 2, 2026
  • Share capital reduction authorized up to 10% via redemption of treasury Class A and Class B shares
  • Board authorized to increase share capital up to 50% over five years, with pre-emptive rights exclusion up to 20%
  • Renewed delegation to list Class A shares on NASDAQ within three years
  • Two independent directors re-elected for four-year terms
  • Remuneration policy amended, raising maximum annual director compensation to EUR 3,500,000
  • Item 11 (15-day notice for extraordinary meetings) not approved

Financial Impact

Dividend distribution of approximately EUR 58.7 million (ordinary + preferred), representing about 1.2% of market cap. Capital reduction and buyback authorizations are permissive, not executed.

dividendshare countcapital structure

Risk Factors

  • Capital increase authorization could lead to dilution if exercised
  • Share buyback and capital reduction are discretionary and may not occur

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-075705
Document: 0001104659-26-075705-index-headers.html0001104659-26-075705
Document: 0001104659-26-075705-index.html0001104659-26-075705
Document: 0001104659-26-075705.txt0001104659-26-075705
5 reports for GRFS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GRFS — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$8.05 $7.75▼ −3.73%▼ −2.81%$7.31 (−9.19%)
Jul 30, 2026
9w ago
6-K
NEUTRAL ★ 2/10
$8.20 $7.82▼ −4.63%▼ −8.60%$7.31 (−10.85%)
Jul 16, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$7.33 $7.93▲ +8.19%▲ +4.57%$7.31 (−0.27%)
Jun 18, 2026
15w ago
6-K
NEUTRAL ★ 3/10
$7.28 $7.27▼ −0.14%▲ +0.01%$7.31 (+0.41%)
Mar 17, 2026
28w ago
Press Release
BULLISH ★ 7/10
$8.02 $8.69▲ +8.35%▲ +4.05%$7.31 (−8.85%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (64h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access